Published in Cancer Weekly, July 13th, 1998
M.F. Ozkaynak, representing colleagues from the New York Medical College, discussed the results of a children's cancer group study at the 34th Annual Meeting of the American Society of Clinical Oncology, held May 16-19, 1998, in Los Angeles, California (abstract "Phase I study of Chimeric Human/Murine Anti-GD2 Monoclonal Antibody (ch14.18) with GM-CSF in Children with Neuroblastoma...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.